Share Capital and Share Premium | 9. Share Capital and Share Premium The authorized share capital of Globus consisted of the following: Share Capital and Share Premium - Authorized share capital December 31, 2022 2021 2020 Authorized share capital: 500,000,000 0.004 2,000 2,000 2,000 100,000,000 0.001 100 100 100 100,000,000 0.001 100 100 100 Total authorized share capital 2,200 2,200 2,200 Holders of the Company’s common shares and Class B common shares have equivalent economic rights, but holders of Company’s common shares are entitled to one vote per share and holders of the Company’s Class B common shares are entitled to twenty votes per share. Share Capital and Share Premium - Common Shares issued and fully paid Common Shares issued and fully paid Number of shares USD As at January 1, 2020 52,235 — Issued during the year for share-based compensation (note 12) 2,812 — Issuance of common stock due to conversion of loan 11,678 — Issuance of new common stocks 2,942,848 12 Issuance of common stock due to exercise of pre-funded warrants 25,000 — Issuance of common stock due to exercise of warrants 5,550 — As at December 31, 2020 3,040,123 12 Issued during the year for share-based compensation (note 12) 12,178 — Issuance of new common stocks 14,905,000 60 Issuance of common stock due to exercise of pre-funded warrants 2,625,000 10 As at December 31, 2021 20,582,301 82 Issued during the year for share-based compensation — — As at December 31, 2022 20,582,301 82 During the years ended December 31, 2021 and 2020, Globus issued 12,178 2,812 0.004 As at December 31, 2022, 2021 and 2020, no 0.001 0 On June 12, 2020, the Company entered into a stock purchase agreement and issued 50 0.001 150 250 150 9. Share Capital and Share Premium (continued) On March 2, 2021, the Company entered into a stock purchase agreement and issued 10,000 0.001 130 During the year ended December 31, 2020, and further to the conversion clause included into the Convertible Note an amount of approximately $ 1,168 100 11,678 0.004 On June 22, 2020, the Company issued 342,857 0.004 35 51,429 0.004 51,429 51,393 0.004 51,393 35 five 12,695 The Class A Warrants are exercisable for a period of five years commencing on the date of issuance. If a registration statement registering the issuance of the common shares underlying the warrants under the Securities Act is not effective or available, the holder may, in its sole discretion, elect to exercise the warrant through a cashless exercise, in which case the holder would receive upon such exercise the net number of common shares determined according to the formula set forth in the warrant. We may be required to pay certain amounts as liquidated damages as specified in the warrants in the event we do not deliver common shares upon exercise of the warrants within the time periods specified in the warrants. As at December 31, 2022 and 2021, the Company had issued 5,550 0.004 194 388,700 388,700 0.004 On June 30, 2020, the Company issued 458,500 0.004 458,500 27 30 18 11,513 On July 21, 2020, the Company issued 833,333 0.004 833,333 18 18 13,950 The PP Warrants are exercisable for a period of five and one-half years commencing on the date of issuance. The warrants are exercisable, at the option of each holder, in whole or in part by delivering to the Company a duly executed exercise notice with payment in full in immediately available funds for the number of common shares purchased upon such exercise. If a registration statement registering the resale of the common shares underlying the private placement warrants under the Securities Act is not effective or available at any time after the six month anniversary of the date of issuance of the private placement warrants, the holder may, in its sole discretion, elect to exercise the private placement warrant through a cashless exercise, in which case the holder would receive upon such exercise the net number of common shares determined according to the formula set forth in the warrant. If the Company does not issue the shares in a timely fashion, the warrant contains certain liquidated damages provisions. As at December 31, 2022 and 2021, no PP Warrants had been exercised and the Company had 1,291,833 1,291,833 On December 10, 2020, the Company entered into a securities purchase agreement with certain unaffiliated institutional investors to issue in a registered direct offering to issue (a) 1,256,765 0.004 155,000 0.004 1,270,587 8.50 1,256,765 0.004 11,159 The December 2020 Pre-Funded Warrants are exercisable at any time after their original issuance until exercised in full. The Pre-Funded Warrants are exercisable, at the option of each holder, in whole or in part by delivering to the Company a duly executed exercise notice with payment in full in immediately available funds for the number of common shares purchased upon such exercise. The exercise price for the December 2020 Pre-Funded Warrants is $0.01 per share. The December 2020 Pre-Funded Warrants are exercisable at any time after their original issuance until exercised in full. 9. Share Capital and Share Premium (continued) As at December 31, 2020, 25,000 0.25 and the Company had 130,000 December 2020 Pre-Funded Warrants outstanding to purchase an aggregate of 130,000 common shares. On January 13, 2021, the remaining 130,000 December 2020 Pre-Funded Warrants were exercised, resulting to net proceeds of approximately $ 1 and the issuance of 130,000 common shares. The December 2020 Warrants are exercisable for a period of five and one-half years commencing on the date of issuance. The warrants are exercisable, at the option of each holder, in whole or in part by delivering to the Company a duly executed exercise notice with payment in full in immediately available funds for the number of common shares purchased upon such exercise. If a registration statement registering the issuance of the common shares underlying the warrants under the Securities Act is not effective, the holder may, in its sole discretion, elect to exercise the warrant through a cashless exercise, in which case the holder would receive upon such exercise the net number of common shares determined according to the formula set forth in the warrant. If the Company does not issue the shares in a timely fashion, the warrant contains certain liquidated damages provisions. As at December 31, 2022 and 2021, no December 2020 Warrants had been exercised and the Company had December 2020 Warrants outstanding to purchase an aggregate of 1,270,587 Total transaction costs for the issuance of common shares in relation to the offerings in 2020 amounted to $ 1,079 On January 29, 2021, the Company entered into a securities purchase agreement with certain unaffiliated institutional investors to issue (a) 2,155,000 0.004 445,000 0.004 1,950,000 0.004 6.25 15,108 120 5 The January 2021 Warrants are exercisable for a period of five and one-half years commencing on the date of issuance. The warrants are exercisable, at the option of each holder, in whole or in part by delivering to the Company a duly executed exercise notice with payment in full in immediately available funds for the number of common shares purchased upon such exercise. If a registration statement registering the issuance of the common shares underlying the warrants under the Securities Act is not effective, the holder may, in its sole discretion, elect to exercise the warrant through a cashless exercise, in which case the holder would receive upon such exercise the net number of common shares determined according to the formula set forth in the warrant. If the Company does not issue the shares in a timely fashion, the warrant contains certain liquidated damages provisions. As at December 31, 2022 and 2021, no January 2021 Warrants had been exercised and the Company had January 2021 Warrants outstanding to purchase an aggregate of 1,950,000 On February 17, 2021, the Company entered into a securities purchase agreement with certain unaffiliated institutional investors to issue (a) 3,850,000 0.004 950,000 0.004 4,800,000 0.004 6.25 27,891 152 10 The February 2021 Warrants are exercisable for a period of five and one-half years commencing on the date of issuance. The warrants are exercisable, at the option of each holder, in whole or in part by delivering to the Company a duly executed exercise notice with payment in full in immediately available funds for the number of common shares purchased upon such exercise. If a registration statement registering the issuance of the common shares underlying the warrants under the Securities Act is not effective, the holder may, in its sole discretion, elect to exercise the warrant through a cashless exercise, in which case the holder would receive upon such exercise the net number of common shares determined according to the formula set forth in the warrant. If the Company does not issue the shares in a timely fashion, the warrant contains certain liquidated damages provisions. As at December 31, 2022 and 2021, no February 2021 Warrants had been exercised and the Company had February 2021 Warrants outstanding to purchase an aggregate of 4,800,000 On June 29, 2021, the Company entered into a securities purchase agreement with certain unaffiliated institutional investors to issue (a) 8,900,000 0.004 1,100,000 0.004 10,000,000 0.004 5.00 46,581 129 11 9. Share Capital and Share Premium (continued) The June 2021 Warrants are exercisable for a period of five and one-half years commencing on the date of issuance. The warrants are exercisable, at the option of each holder, in whole or in part by delivering to the Company a duly executed exercise notice with payment in full in immediately available funds for the number of common shares purchased upon such exercise. If a registration statement registering the issuance of the common shares underlying the warrants under the Securities Act is not effective, the holder may, in its sole discretion, elect to exercise the warrant through a cashless exercise, in which case the holder would receive upon such exercise the net number of common shares determined according to the formula set forth in the warrant. If the Company does not issue the shares in a timely fashion, the warrant contains certain liquidated damages provisions. As at December 31, 2022 and 2021, no June 2021 Warrants had been exercised and the Company had June 2021 Warrants outstanding to purchase an aggregate of 10,000,000 Total transaction costs for the issuance of common shares in relation to the offerings in 2021 amounted to $ 401 The Company’s warrants were classified as equity in accordance with the provisions of IAS 32 meet the classification criteria as per IAS 32 and, accordingly, are classified in equity. Share premium includes the contribution of Globus’ shareholders to the acquisition of the Company’s vessels. Additionally, share premium includes the effects of the Globus initial and follow-on public offerings, the effects of the settlement of the related party loans (note 4) with the issuance of the Company’s common shares and the effects of the share-based payments described in note 12. Accordingly, at December 31, 2022 and 2021, Globus share premium amounted to $ 284,406 195,102 |